We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Researchers Invent New Class of Cancer Immunotherapy Drugs

News   Mar 02, 2018 | Original story from Johns Hopkins

 
Researchers Invent New Class of Cancer Immunotherapy Drugs

Design and bifunctional target binding ability of anti-PDL1-TGFβRII. DOI: 10.1038/s41467-017-02696-6

 
 
 

RELATED ARTICLES

Antibody Injection Temporarily Stops Peanut Allergy

News

A new study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.

READ MORE

A Change in Cell Logistics Helps Cancer Become Resistant

News

Researchers have discovered that breast cancers which had become resistant to hormone therapy have a molecular "advantage" that helps the cells successfully evade hormone therapies.

READ MORE

Could Mimicking How Astronauts Prep for Spaceflight Benefit Cancer Patients?

News

Researchers think that by mimicking an astronaut's schedule of exercising before, during, and after a mission, cancer patients could reduce the long-term impact their treatments can have on their bodies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE